[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fcrzN8VmM0Z28B3QvHRPPdNXmgiMthRIU9S2OTrDBusc":8,"$fjNTbcrKB4a-C_9FnRqsZW2Vq3nCTtM4pgFK2tjQXVMI":54,"$fWseSvfQ6QQQxam2GNtbghRy9bAnbH-RG-QVuecGgWQU":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":25,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":22,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},58095,868672,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","龚理杰","浙江省肿瘤医院","乳腺外科","主治医师",54,0,"乳腺癌 HR+ Her2- 药物治疗实用指南","","https://ystcdn.venuertc.com/venue/AI/0e4baee5-a28a-4d7f-95bb-bdbae8e43fc4.jpg","\u003Cdiv class=\"chuangyi-drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"chuangyi-drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌 HR+ Her2- 药物治疗实用指南\u003C/h2>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">💊\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">为什么要关注HR+ Her2- 乳腺癌的药物治疗？\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      说起来，面对复杂的乳腺肿瘤治疗，药物选择和使用方法其实比想象中要讲究。HR+ Her2- 乳腺癌领域，药物种类多、选择细节多、用法变化多，就像做一道精致的菜肴，每一步都不能马虎。本文将围绕7个核心细节，从药物种类、作用原理到安全注意，一一拆解，帮助大家把握正确用药方法。记住，这只是用药指南，不涉及具体病情内容。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">📋\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">1. 主要用药类型及其具体成分🧬\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      HR+ Her2- 乳腺癌常用的药品主要包括三大类，分别是内分泌治疗药物、CDK4/6抑制剂，以及辅助用药。\n      \u003Cul>\n        \u003Cli>\u003Cstrong>内分泌药物：\u003C/strong>  典型药品有来曲唑（Letrozole）、阿那曲唑（Anastrozole）、他莫昔芬（Tamoxifen）、托瑞米芬（Toremifene）。它们以口服片剂为主，常用规格如来曲唑2.5mg片、阿那曲唑1mg片，他莫昔芬10mg片。\u003C/li>\n        \u003Cli>\u003Cstrong>CDK4/6抑制剂：\u003C/strong> 代表如达尔西利（Dalpiciclib），口服胶囊剂，常见规格为125mg/粒。\u003C/li>\n        \u003Cli>\u003Cstrong>辅助药物：\u003C/strong> 常见有促性腺激素释放激素激动剂（如戈舍瑞林），白细胞生长因子（如重组人粒细胞刺激因子）等，剂型有皮下注射和静脉注射。\u003C/li>\n      \u003C/ul>\n      明确药品全名和规格，是做好用药管理的第一步。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">🧑‍🔬\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">2. 药物机制应该搞清楚\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>内分泌药物\u003C/strong>通过抑制雌激素的生成或阻止雌激素与受体结合，从源头上减少刺激，起到抑制作用。\u003C/li>\n        \u003Cli>\u003Cstrong>CDK4/6抑制剂如达尔西利\u003C/strong>阻断细胞周期的关键节点，让肿瘤细胞“卡壳”、停止分裂（参见 Zhang P, Zhang Q, et al., 2023, \u003Cem>Lancet Oncol\u003C/em>）。\u003C/li>\n        \u003Cli>\u003Cstrong>辅助用药\u003C/strong>则起到升白细胞、供激素等辅助作用，保护身体或减少副作用。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong>了解各类药品的特点和原理，有利于合理搭配和监测用药效果。\n    \u003C/div>\n  \u003C/div>\n   \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">⏰\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">3. 服药时间和方法不可忽略\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>内分泌类药物\u003C/strong>如来曲唑、阿那曲唑、他莫昔芬，建议每天同一时间整片吞服，餐前、餐后均可。搭配足量清水（200ml左右），不建议掰开或研碎。\u003C/li>\n        \u003Cli>\u003Cstrong>达尔西利\u003C/strong>需连续服用3周，休药1周为一周期（“3+1”模式），每日1次，最好在固定时段整粒吞服。此规律服用有助于减少副作用。\u003C/li>\n        \u003Cli>\u003Cstrong>辅助药物\u003C/strong>具体注射时机遵医嘱执行。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>需要注意：\u003C/strong>有位患者在化疗结束后服用达尔西利，因忘记休药周，导致中性粒细胞减少明显。说明按周期正确服药至关重要。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">💡\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">4. 剂型和服用技巧小课堂\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>肠溶片/胶囊：\u003C/strong>如遇到肠溶包衣药物，请勿咀嚼或掰碎，以免药效受影响（常见于部分CDK4/6抑制剂）。\u003C/li>\n        \u003Cli>\u003Cstrong>组合疗法：\u003C/strong>内分泌药物与CDK4/6抑制剂往往要同时服用，两者剂型不同时记得区分药片，避免混淆。\u003C/li>\n        \u003Cli>\u003Cstrong>注射类辅助药物：\u003C/strong>需由专业医护操作，如升白针，注射前后注意注射部位卫生。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong>服药前核对药名和剂量，服用带包衣的药片要整片吞服，避免与其他药品混放。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">⚠️\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">5. 药品相互作用必须警惕\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>CDK4/6抑制剂\u003C/strong>如达尔西利，与强效CYP3A4抑制剂（如酮康唑）、诱导剂（如利福平）同服，会影响药效和安全性。遇到需合用时一定先咨询医生（Xu B, Zhang Q, et al., 2021, \u003Cem>Nat Med\u003C/em>）。\u003C/li>\n        \u003Cli>\u003Cstrong>内分泌药物\u003C/strong>与抗凝药物、止吐药等联合用药时，也有可能改变彼此代谢速率，应避免自行大剂量搭配。\u003C/li>\n        \u003Cli>\u003Cstrong>注射辅助药物\u003C/strong>如用化疗药期间注射升白针，需避免在白细胞正极度减少时注射，否则反应强烈。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>特别提醒：\u003C/strong>服药或换药前，主动告知医生近期使用的所有药物。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">💥\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">6. 常见不良反应——怎么处理更安心\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>CDK4/6抑制剂：\u003C/strong> 患者比较容易感受到白细胞或血小板减少，疲乏、食欲稍降。数据显示，达尔西利引发3级以上中性粒细胞减少率约16.3%（Zhang P, Zhang Q, et al., 2023, \u003Cem>Lancet Oncol\u003C/em>）。\u003C/li>\n        \u003Cli>\u003Cstrong>内分泌药物：\u003C/strong> 他莫昔芬可有体重增加、潮热、轻度下肢水肿等。\u003C/li>\n        \u003Cli>\u003Cstrong>辅助升白针：\u003C/strong> 局部可能出现红肿痛、轻度发热。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong>出现乏力、发热、皮疹等异常反应时，不要自行停药或减少剂量，应及时联系医生。副作用较轻一般可通过调节休药期、加用支持用药改善。有一例老年患者服用CDK4/6抑制剂过程中出现白细胞减少，调整周期后白细胞恢复，完成疗程。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">👵\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">7. 特殊人群的用药选择与剂量调整\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>老年患者：\u003C/strong>监测骨密度和肝肾功能，CDK4/6抑制剂如达尔西利通常不特殊减量，但若不良反应明显，须调整周期或剂量。\u003C/li>\n        \u003Cli>\u003Cstrong>肝肾功能不全：\u003C/strong>CDK4/6抑制剂和内分泌药物均需根据肝肾损害程度调整，有肝功能异常及重度肾损害时特别小心。\u003C/li>\n        \u003Cli>\u003Cstrong>绝经前妇女：\u003C/strong>内分泌药物需配合促性腺激素抑制剂，规范注射时间。\u003C/li>\n        \u003Cli>\u003Cstrong>妊娠和哺乳期：\u003C/strong>绝大多数此类药物禁用于孕妇和哺乳期女性。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong>对高龄或肝肾异常患者定期检测血常规及生化参数，并根据患者耐受性个体化用药方案。\n    \u003C/div>\n  \u003C/div>\n   \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">🗃️\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">8. 储存与过期处理不能大意\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>温度：\u003C/strong>大多数药品储存在室温（15-25℃）避光、干燥处，不宜放入浴室、汽车或阳台等高温潮湿环境。\u003C/li>\n        \u003Cli>\u003Cstrong>开封后：\u003C/strong>按说明书规定期限服用，胶囊类应避免受潮，药片不建议分装其他瓶。\u003C/li>\n        \u003Cli>\u003Cstrong>过期药品：\u003C/strong>不要随意丢弃于垃圾桶，建议送药店或社区回收点集中处理。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong>药品拿回家后贴好标签，定期检查药品有效期和外观。若发现变色、发霉应及时更换新药。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">⏳\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">9. 遇到漏服和服药过量怎么办？\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>漏服：\u003C/strong>发现漏服时，若距离下一次服药时间较远，可及时补服。临近下一次则跳过，严禁双倍服药。\u003C/li>\n        \u003Cli>\u003Cstrong>服药过量：\u003C/strong>如意外多服，需立即报告医生，配合血象及肝肾功能检查。出现头晕、恶心等明显不适时应尽快就医处理。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>操作建议：\u003C/strong>建议自备服药记录表，每次用药后及时勾选，也可以用闹钟和手机提醒辅助。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">📖\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">10. 临床用药经验分享\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      \u003Cul>\n        \u003Cli>一位67岁女性完成手术后，在辅助治疗期间使用达尔西利联合来曲唑方案，因规律服药与监测，药物耐受性良好，未出现严重不良反应。\u003C/li>\n        \u003Cli>部分患者在化疗结束后启用CDK4/6抑制剂，因未严格按照\"3+1\"周期服药导致白细胞波动，经医师指导后恢复规律性，血象平稳。\u003C/li>\n        \u003Cli>老年群体调整剂量后，结合辅助升白针应用，有效减轻副作用，顺利完成疗程。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>这些经验说明：\u003C/strong>规范用药、按周期管理、副反应监测，是保证药物发挥最大效果的关键。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">🔚\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">结语 & 用药小结\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg\">\n      综合来看，HR+ Her2- 乳腺癌辅助用药方案以内分泌药和CDK4/6抑制剂为主，其关键优势在于联合疗法、周期规律和安全可控。但是，每一种药物的剂型、服用方法、周期和相互作用都有细致考量。如果想让药效稳定、安全地发挥，\u003Cstrong>服药规律、关注副反应、定期检查和主动沟通\u003C/strong>，这四点缺一不可。如有疑问及时找专业医生协助，自行随意增减药量或更换方案风险极大。科学用药，才能守护健康。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"chuangyi-guide-section\">\n    \u003Cdiv class=\"chuangyi-section-header\">\n      \u003Cspan class=\"chuangyi-section-emoji\">📚\u003C/span>\n      \u003Cspan class=\"chuangyi-section-title\">参考文献\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"chuangyi-section-bg chuangyi-ref-bg\">\n      \u003Col>\n        \u003Cli>Zhang P, Zhang Q, Tong Z, et al. (2023). Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. \u003Ci>Lancet Oncology\u003C/i>, 24(6), 646-657. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37182538/\" target=\"_blank\">[PubMed]\u003C/a>\u003C/li>\n        \u003Cli>Xu B, Zhang Q, Zhang P, et al. (2021). Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial. \u003Ci>Nature Medicine\u003C/i>, 27(11), 1904-1909. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34737452/\" target=\"_blank\">[PubMed]\u003C/a>\u003C/li>\n        \u003Cli>Pan H, Gray R, Braybrooke J, et al. (2017). 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. \u003Ci>New England Journal of Medicine\u003C/i>, 377, 1836–1846. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29117498/\" target=\"_blank\">[PubMed]\u003C/a>\u003C/li>\n        \u003Cli>Santander Ballestín S, et al. (2025). Advances in CDK4 and 6 Inhibitors: Transforming Breast Cancer Treatment. \u003Ci>Cancers (Basel)\u003C/i>, 17(5):760. \u003Ca href=\"https://www.mdpi.com/2072-6694/17/5/760\" target=\"_blank\">[MDPI]\u003C/a>\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.chuangyi-drug-guide-container {\n  font-family: 'Segoe UI', Arial, sans-serif;\n  background-color: #fcfcfd;\n  color: #22313e;\n  max-width: 890px;\n  margin: 38px auto 48px auto;\n  border-radius: 18px;\n  padding: 38px 32px 50px 32px;\n  box-shadow: 0 6px 20px 0 rgba(45, 55, 120, 0.08), 0 1.5px 6px 0 rgba(45,55,120,0.03);\n  box-sizing: border-box;\n}\n.chuangyi-drug-guide-title {\n  text-align: center;\n  font-size: 34px;\n  font-weight: 700;\n  color: #17375c;\n  margin-bottom: 22px;\n  letter-spacing: 1px;\n  border-bottom: 2px solid #e4e8ef;\n  padding-bottom: 15px;\n  background: linear-gradient(90deg, #e6eeff 30%, #e8f2e9 100%);\n  border-radius: 6px;\n}\n.chuangyi-guide-section {\n  margin-bottom: 26px;\n  padding-bottom: 0;\n}\n.chuangyi-section-header {\n  display: flex;\n  align-items: center;\n  font-size: 22px;\n  font-weight: 600;\n  background: linear-gradient(87deg, #e7edfa 60%, #f3faf5 100%);\n  border-radius: 7px 7px 0 0;\n  padding: 12px 18px 10px 12px;\n  margin-bottom: 0;\n  min-height: 32px;\n  letter-spacing: 0.5px;\n}\n.chuangyi-section-emoji {\n  font-size: 27px;\n  margin-right: 11px;\n  line-height: 1;\n}\n.chuangyi-section-title {\n  vertical-align: middle;\n  color: #1d3557;\n}\n.chuangyi-section-bg {\n  background: linear-gradient(114deg, #f8fafd 84%, #f9fcfa 100%);\n  padding: 22px 28px 19px 22px;\n  border-radius: 0 0 7px 7px;\n  font-size: 17px;\n  line-height: 1.82;\n  box-sizing: border-box;\n  margin-bottom: 2px;\n}\n.chuangyi-section-bg ul {\n  padding-left: 20px;\n  margin: 14px 0;\n}\n.chuangyi-section-bg li {\n  margin-bottom: 8px;\n  font-size: 17px;\n}\n.chuangyi-ref-bg {\n  background: linear-gradient(90deg, #edf1fa 60%, #f5faf6 100%);\n  font-size: 16px;\n  line-height: 1.7;\n}\n.chuangyi-section-bg strong {\n  color: #235588;\n  font-weight: 600;\n}\n@media (max-width: 750px) {\n  .chuangyi-drug-guide-container {\n    max-width: 98vw !important;\n    margin: 12px 7px 14px 7px !important;\n    padding: 13px 5vw 20px 6vw !important;\n    font-size: 15px !important;\n  }\n  .chuangyi-drug-guide-title {\n    font-size: 22px !important;\n    padding-bottom: 8px !important;\n  }\n  .chuangyi-section-header {\n    font-size: 17px !important;\n    padding: 7px 10px 6px 8px !important;\n    min-height: 24px !important;\n  }\n  .chuangyi-section-emoji {\n    font-size: 21px !important;\n    margin-right: 7px !important;\n  }\n  .chuangyi-section-bg {\n    font-size: 15px !important;\n    padding: 12px 9px 10px 9px !important;\n  }\n}\n\u003C/style>\n",463,"2025-08-11 11:54:38","乳腺癌, HR+ Her2- 药物, CDK4/6抑制剂, 内分泌治疗, 用药指南, 剂量调整, 不良反应, 患者注意事项","本文深入解析HR+ Her2-乳腺癌的药物治疗方法，从药物类型到服药技巧，帮助患者科学用药，确保治疗效果。","2025-08-23 08:10:00",2,[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]